在神经退行性疾病中的补充疗法
Wioleta M Zelek1, Andrea J Tenner2
1UK Dementia Research Institute, School of Medicine, CF14 4XN, Cardiff University, UK.
Immunobiology
|June 22, 2025
概括
补体系统在大脑健康和神经退行性疾病中起着关键作用. 针对这个系统为各种大脑疾病提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经退行性疾病 (NDD) 存在重大治疗挑战,部分原因是药物必须穿越血脑屏障.
- 炎症是NDD的关键组成部分,补体系统成为中枢神经系统 (CNS) 中的中心调解者.
- 补体系统的调节失调有助于突触损失,慢性炎症和神经退行,并与神经发育和精神疾病有关.
研究的目的:
- 提供对补充系统在中枢神经系统健康和疾病中的作用的全面概述.
- 总结补充对神经病理学的贡献机制.
- 讨论中枢神经系统药物开发中的新型治疗策略和挑战.
主要方法:
- 审查关于中枢神经系统中补充系统的现有文献.
- 对补体在神经退行性,神经发育性和神经精神疾病中的参与进行分析.
- 对中枢神经系统疾病的治疗方法和药物输送挑战的检查.
主要成果:
- 补体系统参与正常的大脑功能,如突触修剪和免疫监测.
- 在NDD中,异常补充激活驱动神经炎症,突触损失和神经退行.
- 补充系统过度激活会影响精神病和神经发育条件下的大脑发育和电路稳定性.
结论:
- 补体系统是中枢神经系统健康和疾病的关键因素.
- 准补体系统为神经退行性和其他大脑疾病提供了一个新的治疗途径.
- 克服大脑药物输送和患者分层方面的挑战对于开发有效的基于补充的疗法至关重要.
相关概念视频
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
214
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214
Complement System
2.8K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.8K
Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722
Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391


